Disease implications of the Hippo/YAP pathway - PubMed (original) (raw)
Review
Disease implications of the Hippo/YAP pathway
Steven W Plouffe et al. Trends Mol Med. 2015 Apr.
Abstract
The Hippo signaling pathway is important for controlling organ size and tissue homeostasis. Originally identified in Drosophila melanogaster, the core components of the Hippo pathway are highly conserved in mammals. The Hippo pathway can be modulated by a wide range of stimuli, including G protein-coupled receptor (GPCR) signaling, changes in the actin cytoskeleton, cell-cell contact, and cell polarity. When activated, the Hippo pathway functions as a tumor suppressor to limit cell growth. However, dysregulation by genetic inactivation of core pathway components or amplification or gene fusion of its downstream effectors results in increased cell proliferation and decreased apoptosis and differentiation. Unsurprisingly, this can lead to tissue overgrowth, tumorigenesis, and many other diseases.
Keywords: Hippo; TAZ; YAP; cancer; disease.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Figures
Figure 1. The Hippo signaling pathway
When the Hippo pathway is activated, MST1/2 in complex with SAV1 phosphorylate and activate LATS1/2 and MOB1. When activated, LATS1/2 phosphorylates YAP/TAZ, the primary effectors of the Hippo pathway. When phosphorylated, YAP/TAZ are sequestered in the cytoplasm or degraded. When YAP/TAZ are dephosphorylated, they translocate to the nucleus where they interact with TEAD1-4 to induce transcription and promote cell proliferation and inhibit apoptosis. Arrows and blunt ends indicate activation and inhibition, respectively.
Figure 2. Disease implications of the Hippo pathway
Dysregulation of the Hippo pathway has been implicated in a number of cancers and diseases throughout the body. Dysregulation may be due to genetic inactivation of core pathway components or amplification or gene fusion of its downstream effectors YAP and TAZ. Here we briefly summarize some of the diseases covered in this review.
Similar articles
- YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.
Zhang J, Ji JY, Yu M, Overholtzer M, Smolen GA, Wang R, Brugge JS, Dyson NJ, Haber DA. Zhang J, et al. Nat Cell Biol. 2009 Dec;11(12):1444-50. doi: 10.1038/ncb1993. Epub 2009 Nov 22. Nat Cell Biol. 2009. PMID: 19935651 Free PMC article. - Hippo signaling promotes JNK-dependent cell migration.
Ma X, Wang H, Ji J, Xu W, Sun Y, Li W, Zhang X, Chen J, Xue L. Ma X, et al. Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):1934-1939. doi: 10.1073/pnas.1621359114. Epub 2017 Feb 7. Proc Natl Acad Sci U S A. 2017. PMID: 28174264 Free PMC article. - A role for Hipk in the Hippo pathway.
Heidary Arash E, Attisano L. Heidary Arash E, et al. Sci Signal. 2013 May 14;6(275):pe18. doi: 10.1126/scisignal.2004259. Sci Signal. 2013. PMID: 23674821 Review. - Hippo-Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior.
van Soldt BJ, Cardoso WV. van Soldt BJ, et al. Wiley Interdiscip Rev Dev Biol. 2020 May;9(3):e371. doi: 10.1002/wdev.371. Epub 2019 Dec 11. Wiley Interdiscip Rev Dev Biol. 2020. PMID: 31828974 Free PMC article. Review. - The regulation and function of YAP transcription co-activator.
Zhu C, Li L, Zhao B. Zhu C, et al. Acta Biochim Biophys Sin (Shanghai). 2015 Jan;47(1):16-28. doi: 10.1093/abbs/gmu110. Epub 2014 Dec 8. Acta Biochim Biophys Sin (Shanghai). 2015. PMID: 25487920 Review.
Cited by
- Emerging role and function of Hippo-YAP/TAZ signaling pathway in musculoskeletal disorders.
Han J, Zhang J, Zhang X, Luo W, Liu L, Zhu Y, Liu Q, Zhang XA. Han J, et al. Stem Cell Res Ther. 2024 Oct 29;15(1):386. doi: 10.1186/s13287-024-04011-9. Stem Cell Res Ther. 2024. PMID: 39468616 Free PMC article. Review. - Interplay of Glucose Metabolism and Hippo Pathway in Chondrocytes: Pathophysiology and Therapeutic Targets.
Jahn J, Ehlen QT, Kaplan L, Best TM, Meng Z, Huang CY. Jahn J, et al. Bioengineering (Basel). 2024 Sep 27;11(10):972. doi: 10.3390/bioengineering11100972. Bioengineering (Basel). 2024. PMID: 39451348 Free PMC article. Review. - Hippo Signaling Pathway in Colorectal Cancer: Modulation by Various Signals and Therapeutic Potential.
Mohammadpour S, Torshizi Esfahani A, Sarpash S, Vakili F, Zafarjafarzadeh N, Mashaollahi A, Pardakhtchi A, Nazemalhosseini-Mojarad E. Mohammadpour S, et al. Anal Cell Pathol (Amst). 2024 Oct 11;2024:5767535. doi: 10.1155/2024/5767535. eCollection 2024. Anal Cell Pathol (Amst). 2024. PMID: 39431199 Free PMC article. Review. - Transcription repression of estrogen receptor alpha by ghrelin/Gq/11/YAP signaling in granulosa cells promotes polycystic ovary syndrome.
Zhu P, Bi X, Su D, Li X, Chen Y, Song Z, Zhao L, Wang Y, Xu S, Wu X. Zhu P, et al. Hum Cell. 2024 Nov;37(6):1663-1678. doi: 10.1007/s13577-024-01127-1. Epub 2024 Sep 3. Hum Cell. 2024. PMID: 39225978 - The Emerging Role of Ubiquitin-Specific Protease 36 (USP36) in Cancer and Beyond.
Niu MY, Liu YJ, Shi JJ, Chen RY, Zhang S, Li CY, Cao JF, Yang GJ, Chen J. Niu MY, et al. Biomolecules. 2024 May 12;14(5):572. doi: 10.3390/biom14050572. Biomolecules. 2024. PMID: 38785979 Free PMC article. Review.
References
- Callus BA, et al. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J. 2006;273:4264–4276. - PubMed
- Tapon N, et al. salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines. Cell. 2002;110:467–478. - PubMed
- Chan EH, et al. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene. 2005;24:2076–2086. - PubMed
- Huang J, et al. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell. 2005;122:421–434. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 EY022611/EY/NEI NIH HHS/United States
- R01 CA132809/CA/NCI NIH HHS/United States
- EYO226116/PHS HHS/United States
- CA132809/CA/NCI NIH HHS/United States
- R01 CA108941/CA/NCI NIH HHS/United States
- P30 CA023100/CA/NCI NIH HHS/United States
- T32 GM007752/GM/NIGMS NIH HHS/United States
- P30CA023100/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources